Kineta
Entity

  • Kineta

    Created in 2008
  • BETA

    Up & running (A)
    Existing signals show a regular activity

  • Social networks

    920 3,635 3,635

  • Activities

    biotech deeptech

  • Entity types

    Startup

  • Location

    Seattle, WA, USA

    Seattle

    United States of America

  • Employees

    Scale: 11-50

    Estimated: 29

  • Engaged corporates

    4
    0 3

  • Added in Motherbase

    1 year, 6 months ago
Description
  • Value proposition

    KA (Nasdaq)
    Developing next-generation immunotherapies for cancer patients!

    Kineta is a clinical stage biotechnology company with a mission to develop next-generation immunotherapies that transform patients’ lives.

    Antivirals, Chronic Pain, Immuno-oncology, Biodefense, Immunology, Virology, Lassa fever, and Neuroscience

  • Next-generation immunotherapies for cancer patients – Kineta Inc.

    Kineta fills a void in the biopharmaceutical industry by efficiently advancing first-in-class novel immunotherapies from discovery to proof of concept.

    • https://kinetabio.com/
Corporate interactions BETA
Corporate TypeTweets Articles
Biotechnology Innovation Organization
Biotechnology Innovation Organization
Biotechnology Innovation Organization
Other

29 Sep 2023


Amgen
Amgen
Biotechnology, Biotechnology Research
Amgen
Biotechnology, Biotechnology Research 		Other

28 Aug 2018


MSD
MSD
Pharmaceutical, Pharmaceutical Manufacturing
MSD
Pharmaceutical, Pharmaceutical Manufacturing 		Other

11 Jan 2022


Nasdaq
Nasdaq
Finance, Financial Services
Nasdaq
Finance, Financial Services 		Other

23 Dec 2020

27 Jul 2023



Similar entities
Last news
Show all articles
Social network dynamics